72498-23-8 Usage
Description
(6aS)-5,6,6a,7-Tetrahydro-1,2,9,10-tetramethoxy-6-methyl-4H-dibenzo[de,g]quinoline 6-oxide is a complex chemical compound that belongs to the class of dibenzylisoquinoline alkaloids. It is derived from natural sources and has been identified for its potent antioxidant properties, along with anti-inflammatory and anti-cancer activities. (6aS)-5,6,6a,7-Tetrahydro-1,2,9,10-tetramethoxy-6-methyl-4H-dibenzo[de,g]quinoline 6-oxide's unique structure and biological profile make it a promising candidate for research and development within the pharmaceutical and nutraceutical industries.
Uses
Used in Pharmaceutical Applications:
(6aS)-5,6,6a,7-Tetrahydro-1,2,9,10-tetramethoxy-6-methyl-4H-dibenzo[de,g]quinoline 6-oxide is used as a therapeutic agent for its anti-inflammatory and anti-cancer properties. Its antioxidant capabilities contribute to its potential in treating various diseases and conditions where oxidative stress plays a significant role.
Used in Nutraceutical Applications:
In the nutraceutical industry, (6aS)-5,6,6a,7-Tetrahydro-1,2,9,10-tetramethoxy-6-methyl-4H-dibenzo[de,g]quinoline 6-oxide is utilized as an additive for its antioxidant and health-promoting benefits. It may be incorporated into dietary supplements and functional foods to enhance their nutritional value and support overall health.
Used in Research and Development:
(6aS)-5,6,6a,7-Tetrahydro-1,2,9,10-tetramethoxy-6-methyl-4H-dibenzo[de,g]quinoline 6-oxide is also used in the research and development sector as a subject of interest for scientists and pharmaceutical companies. Its unique structure and biological activities make it a valuable tool for studying the mechanisms of various diseases and for developing new drugs and treatments.
Used in Antioxidant Formulations:
Due to its potent antioxidant nature, (6aS)-5,6,6a,7-Tetrahydro-1,2,9,10-tetramethoxy-6-methyl-4H-dibenzo[de,g]quinoline 6-oxide can be used in the formulation of antioxidant products, which are essential in the cosmetic and personal care industry to prevent cellular damage and promote skin health.
Used in Drug Delivery Systems:
Similar to other bioactive compounds, (6aS)-5,6,6a,7-Tetrahydro-1,2,9,10-tetramethoxy-6-methyl-4H-dibenzo[de,g]quinoline 6-oxide may benefit from novel drug delivery systems to enhance its bioavailability, targeting, and therapeutic efficacy. This application could involve the use of nanoparticles or other advanced delivery mechanisms to improve the compound's performance in medical treatments.
Check Digit Verification of cas no
The CAS Registry Mumber 72498-23-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,2,4,9 and 8 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 72498-23:
(7*7)+(6*2)+(5*4)+(4*9)+(3*8)+(2*2)+(1*3)=148
148 % 10 = 8
So 72498-23-8 is a valid CAS Registry Number.
InChI:InChI=1/C21H25NO5/c1-22(23)7-6-12-9-18(26-4)21(27-5)20-14-11-17(25-3)16(24-2)10-13(14)8-15(22)19(12)20/h9-11,15H,6-8H2,1-5H3/t15-,22?/m0/s1
72498-23-8Relevant articles and documents
A facile method for the synthesis of glaucine and norglaucine from boldine
Huang, Wei-Jan,Chen, Chung-Hsiung,Singh, Om V.,Lee, Su-Lin,Lee, Shoei-Sheng
, p. 3681 - 3686 (2007/10/03)
A large-scale preparation of glaucine was achieved by reacting boldine with trimethylphenylammonium chloride and potassium t-butoxide in high yield. Treatment of glaucine with 30% H202, subsequent with hydrated ferrous sulfate, afforded norglaucine in an overall yield of 40%.
